Literature DB >> 32055268

Lymphadenopathy in POEMS syndrome: a correlation between clinical features and imaging findings.

Xiao-Feng Shi1,2, Shu-Dong Hu3, Li-Li Wu2, Xiao-Yan Chen2, Jian-Nong Wu1, Xian-Qiu Yu1, Dong-Ya Li1, Min Chen1, Yi-Chen Liu1, Yan Zhu1, Xiao-Dong Xi2.   

Abstract

Lymphadenopathy is an important characteristic of POEMS syndrome, and a Castleman disease (CD)-like pathologic change in the lymph nodes is one of the major diagnostic criteria. However, the characteristics of lymphadenopathy in POEMS still have not been completely elucidated. The lymph node biopsies are available only for a small proportion of patients. A simple and safe way is needed to rule CD in or out. This study aimed to analyse the features of lymphadenopathy and estimate the role of imaging methods, including computed tomography (CT) and positron emission tomography-CT (PET/CT), in the diagnosis of lymphadenopathy in patients with POEMS syndrome. We conducted a retrospective analysis of 23 patients with confirmed POEMS syndrome. All of the patients received chest and abdominal CT scan and/or superficial ultrasound examinations. Four patients underwent PET/CT examinations, and 6 patients received lymph node biopsies. Enlarged lymph nodes (short diameter ≥ 1 cm) were found in 48% (11/23) of patients, but only 1 patient had an enlarged lymph node with a diameter ≥ 2 cm. Lymph nodes with CD-like pathologic changes from 2 patients showed increased maximum standard uptake values (SUVmax) of 18F-deoxyglucose (18FDG) on PET/CT, while lymph nodes with reactive pathologic changes from 2 other patients showed a normal metabolic PET/CT profile. The extent of lymph node enlargement in patients with POEMS was less than that in patients with CD per se. We draw the conclusion that most of the enlarged lymph nodes had diameters ≤ 2 cm, which is less than that in cases of CD per se and PET/CT may be helpful in determining whether enlarged lymph nodes are characterized by CD-like changes or not. IJCEP
Copyright © 2020.

Entities:  

Keywords:  Castleman disease; PET/CT; POEMS syndrome; lymphadenopathy

Year:  2020        PMID: 32055268      PMCID: PMC7013372     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  15 in total

1.  Unicentric and multicentric Castleman's disease.

Authors:  K Enomoto; I Nakamichi; K Hamada; A Inoue; I Higuchi; M Sekimoto; M Mizuki; Y Hoshida; T Kubo; K Aozasa; J Hatazawa
Journal:  Br J Radiol       Date:  2007-01       Impact factor: 3.039

2.  Clinical characteristics and long-term outcome of patients with POEMS syndrome in China.

Authors:  Jian Li; Dao-Bin Zhou; Zhen Huang; Li Jiao; Ming-Hui Duan; Wei Zhang; Yong-Qiang Zhao; Ti Shen
Journal:  Ann Hematol       Date:  2011-01-08       Impact factor: 3.673

3.  Clinicopathologic analysis of POEMS syndrome and related diseases.

Authors:  Xiaofeng Shi; Shudong Hu; Xianqiu Yu; Qin Zhuang; Min Luo; Qian Jiang; Lixia Wang; Yilong Lu; Xiaoming Fei; Xiaodong Xi; Yan Zhu
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-07-23

4.  Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication.

Authors:  Eun Seong Lee; Jin Chul Paeng; Chang Min Park; Won Chang; Won Woo Lee; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Clin Nucl Med       Date:  2013-05       Impact factor: 7.794

Review 5.  Castleman Disease of the Thorax: Clinical, Radiologic, and Pathologic Correlation: From the Radiologic Pathology Archives.

Authors:  Seth J Kligerman; Aaron Auerbach; Teri J Franks; Jeffrey R Galvin
Journal:  Radiographics       Date:  2016 Sep-Oct       Impact factor: 5.333

Review 6.  POEMS syndrome.

Authors:  Angela Dispenzieri
Journal:  Blood Rev       Date:  2007-09-11       Impact factor: 8.250

Review 7.  New advances in the diagnosis and treatment of POEMS syndrome.

Authors:  Jian Li; Dao-bin Zhou
Journal:  Br J Haematol       Date:  2013-02-08       Impact factor: 6.998

8.  18F-FDG PET/CT in the evaluation of POEMS syndrome.

Authors:  M A Albertí; S Martinez-Yélamos; A Fernandez; A Vidaller; J A Narváez; L M Cano; C Gamez; J A Martinez-Matos
Journal:  Eur J Radiol       Date:  2009-07-05       Impact factor: 3.528

Review 9.  POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2014-02       Impact factor: 10.047

10.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.